The serum albumin level and number of patients with history of cardiovascular diseases (CVD) in the development data group were significantly higher than those of the validation data set (serum albumin: p = 0.001, history of CVD: p = 0.010). The gene discussed is ALB; the disease is cardiovascular disorder.